Cannabis indica
More actions
Cannabis indica Lam. is a historical botanical name originally published by Lamarck in 1785 for Indian drug-type cannabis specimens collected by Pierre Sonnerat.[1][2] Its taxonomic status remains disputed. Major plant-name databases such as Plants of the World Online and World Flora Online currently treat C. indica Lam. as a synonym of Cannabis sativa L., while cannabis-specific taxonomic literature commonly retains indica-type plants at subspecies or variety rank within a monotypic C. sativa.[3][4][5]
In the cannabis-specific literature, three positions persist. Monotypic treatments recognise only Cannabis sativa L. and place indica-type plants at infraspecific rank or treat them as synonyms.[3][4][6] Polytypic treatments after Schultes et al. (1974) recognise C. indica as a distinct species, sometimes alongside Cannabis ruderalis.[7][8] Intermediate treatments reduce indica-type plants to subspecific rank within C. sativa.[3][5][9] A widely cited formal treatment in this last group, Small and Cronquist (1976), places drug-type plants as C. sativa subsp. indica (Lam.) E. Small & Cronquist.[3]
In the influential revision of McPartland and Small (2020), Asian high-THC domesticates are placed in C. sativa subsp. indica, with South Asian narrow-leaflet plants treated as var. indica (Lamarck's original concept) and Central Asian broad-leaflet plants as var. afghanica (originally described by Vavilov in the early twentieth century), together with two wild varieties.[5] This four-variety treatment provides a current framework for describing the range of plants typically labelled Cannabis indica.
Taxonomic history
Linnaeus described a single species of Cannabis in 1753 based on European hemp cultivars.[10] In 1785, Lamarck published a description of a second species, Cannabis indica, in the first volume of the Encyclopédie Méthodique.[1] The type material consisted of specimens collected in India by Pierre Sonnerat, probably in the vicinity of Pondicherry between 1775 and 1778.[5][2] Lamarck listed eight morphological characters distinguishing C. indica from C. sativa, including a firmer and more woody stem, denser branching, narrower leaflets and a velvety perigonal bract on the pistillate flower bearing dense glandular pubescence.[2] He also recorded chemotaxonomic differences: C. indica produced a strong odour and was reported to cause intoxication when smoked.[2]
Through the nineteenth century, C. indica was variously treated as a species, as a variety of C. sativa (as C. sativa var. indica (Lam.) Wehmer 1911) or as a synonym of C. sativa depending on the author.[4] Vavilov's expeditions to Afghanistan and Central Asia in the 1920s documented a morphologically distinct population that he initially described as C. sativa f. afghanica (Vavilov 1926) and later as C. indica var. afghanica (Vavilov 1929), characterised by short stature, broad leaflets, dense branching and adaptation to arid montane conditions.[11][5] Vavilov characterised afghanica as a morphological link between cultivated drug plants and wild populations of South and Central Asia.[5]
Schultes and colleagues (1974) revived the polytypic concept with a three-species treatment recognising C. sativa (fibre hemp), C. indica (drug-type plants from the Hindu Kush) and C. ruderalis (wild Russian populations).[7] Under this treatment, the Hindu Kush broad-leaf drug form became the practical exemplar of Schultes's C. indica concept, despite differing from Lamarck's original South Asian type material. Small and Cronquist (1976) rejected this expansion and reduced the indica concept to a subspecies within a polymorphic C. sativa, distinguishing subsp. sativa (low-THC fibre and oilseed forms) from subsp. indica (high-THC drug-type forms).[3]
Hillig (2005), in a wide-ranging allozyme study, found genetic support for two principal gene pools corresponding broadly to hemp and drug types, with the drug-type gene pool further partitioned into a narrow-leaflet drug (NLD) component originating in South and Southeast Asia and a wide-leaflet drug (WLD) component originating in Central Asia.[8] The NLD/WLD distinction maps onto Lamarck's South Asian C. indica on the one hand and Vavilov's Afghan afghanica on the other.[5] Hillig framed his results as consistent with either a single-species or multi-species interpretation.[8]
McPartland and Small (2020) restated the two-subspecies treatment of Small and Cronquist with reference to genetic and morphological data accumulated since 1976, and introduced four varieties within subsp. indica to accommodate Lamarck's South Asian type, Vavilov's Central Asian afghanica and their respective wild relatives.[5] Lapierre and colleagues (2023) reviewed genomic data on cannabis classification and concluded in favour of a monotypic C. sativa with infraspecific structure rather than three discrete species.[9]
Recent molecular work has generally favoured or been compatible with a monotypic treatment, while recovering strong geographic and use-type structure within Cannabis. Whole-genome resequencing by Ren et al. (2021) placed basal divergence of Cannabis in the eastern Tibetan Plateau region and identified an early split between hemp and drug lineages.[12] Lynch et al. (2025) built a 193-genome pangenome representing 156 biological samples (including 12 previously published assemblies) and reported high genetic and structural diversity within C. sativa, proposing a revised population structure and hybridisation history.[13] Hyb-Seq phylogeography by Balant et al. (2025) supports a monotypic Cannabis structured into three principal groups (East Asia, Paleotropis, Boreal). Within the Paleotropis, traditional indica-type accessions cluster across three subgroups: the Iranian Plateau (Afghan and Hindu Kush landraces), the Central and Southern China and Himalayas (northern Indian landraces) and the Indoafrica (dispersed South Asian-origin populations from Southeast Asia, southern India and West Africa).[6]
Subspecies and varieties
The treatment of McPartland and Small (2020) recognises four varieties within C. sativa subsp. indica, distinguishing domesticated and wild forms in each of the two principal geographic regions.[5]
- C. sativa subsp. indica var. indica (Lam.) Persoon, the domesticated South Asian narrow-leaflet drug type. Plants typically grow above two metres, with relatively long internodes, narrow leaflets (central leaflet length-to-width ratio ≥ 6) and elongated, less densely flowered inflorescences. Type locality is India, based on Lamarck's specimens from Pondicherry. Distributed from South Asia eastward through Southeast Asia and southward into Africa following historical trade routes.[5][14]
- C. sativa subsp. indica var. afghanica (Vavilov) McPartland & E. Small, the domesticated Central Asian wide-leaflet drug type. Plants are typically shorter than two metres, with short internodes, broad leaflets (central leaflet length-to-width ratio < 6), woody stems and conical, densely flowered inflorescences. Type locality designated near Kandahar, Afghanistan. Distributed in the Hindu Kush and adjacent regions of Afghanistan, Pakistan and Turkestan.[5]
- C. sativa subsp. indica var. himalayensis (Vavilov) McPartland & E. Small, the wild relative of var. indica. Distributed across the western Himalayas and adjacent foothills.[5]
- C. sativa subsp. indica var. asperrima (Regel) McPartland & E. Small, the wild relative of var. afghanica. Distributed across Central Asia and adjacent ranges.[5]
The four-variety treatment maps onto Hillig's NLD/WLD genetic distinction: var. indica corresponds to NLD South Asian populations, var. afghanica to WLD Central Asian populations, with the two wild varieties representing the respective ancestral or feral pools.[5][8] In the molecular geography of Balant et al. (2025), traditional landraces of var. afghanica fall within the Iranian Plateau subgroup of the Paleotropis group; northern Indian landraces representative of var. indica fall within the Central and Southern China and Himalayas subgroup; and Indoafrican drug-type accessions (including landraces from Thailand, Cambodia, Sri Lanka, southern India and West Africa) fall within the Indoafrica subgroup of the same group.[6]
Description
The description below emphasises features that distinguish indica-type plants from hemp-type Cannabis sativa subsp. sativa. Many characters vary continuously across populations and the two subspecies are not morphologically distinct in the strict sense; the distinction is between modal forms rather than discrete categories.[4]
Habit
Cannabis indica is an erect annual herb. Var. indica plants typically grow above two metres in productive sites, with relatively long internodes and a tall, branching habit comparable to fibre forms of C. sativa subsp. sativa.[5] Var. afghanica plants are characteristically shorter, often reaching only one to two metres in cultivation, with shorter internodes, denser branching and a more conical overall form.[5][14] Stems of var. afghanica are woodier and more rigid than those of var. indica and tropical drug forms generally, a feature first noted by Lamarck (1785) and reiterated by Schultes et al. (1974) and McPartland and Small (2020).[1][7][5][2]
Leaves
Narrow-leaflet drug (NLD) plants, corresponding to var. indica, bear palmately compound leaves with five to thirteen lanceolate leaflets per mature leaf, with a central-leaflet length-to-width ratio of 6 or greater.[5][8] Wide-leaflet drug (WLD) plants, corresponding to var. afghanica, bear leaves with five to nine wider leaflets, with a length-to-width ratio less than 6 and often as low as 3 to 4.[5][14] WLD leaflets are typically a darker green than NLD leaflets, with shorter petioles and shorter internodes between successive leaves on the stem.[14] Leaflet number and width vary within both varieties, and intermediate phenotypes are common in hybrid populations.[4]
Flowers
Plants are predominantly dioecious and wind-pollinated, as in other Cannabis; monoecious individuals occur naturally at low frequency and can be induced by environmental stress or photoperiod manipulation.[4][13] Pistillate inflorescences of var. afghanica are typically denser and more compact than those of var. indica and of fibre-type subsp. sativa, a consequence of shorter internodes within the inflorescence and a higher density of pistillate flowers per node.[14][5] Perigonal bracts in both varieties are densely covered with capitate-stalked glandular trichomes, more so than in fibre hemp; the dense glandular pubescence on the pistillate "calyx" was among the eight characters Lamarck used to distinguish C. indica in 1785.[2]
Trichomes
Aerial surfaces of drug-type Cannabis indica bear high densities of capitate-stalked glandular trichomes on the perigonal bracts and surrounding leaves of the pistillate inflorescence.[15] These trichomes are the principal site of cannabinoid and terpenoid biosynthesis and accumulate the cannabinoids and terpenoids for which drug-type Cannabis is grown.[15][16] Var. afghanica is commonly cultivated for production of compressed resin (hashish), reflecting both the trichome density of the plant and the traditional processing methods of its core distribution region.[14]
Fruits and seeds
The fruit is an achene, as in other Cannabis.[4] McPartland and Small (2020) note that mature achenes of var. indica and var. afghanica are typically 3.6 mm or greater in length, with the perianth largely sloughed off at maturity, lacking the prominent protuberant base and the well-developed abscission zone characteristic of wild varieties.[5] Wild var. himalayensis and var. asperrima retain seed-shattering and a more persistent perianth, consistent with self-dispersal in unmanaged populations.[5]
Distribution
The centre of geographic origin of Cannabis indica lies in temperate Asia, with two distinct historical foci: South Asia for var. indica and its wild relative var. himalayensis, and Central Asia, particularly the Hindu Kush of Afghanistan and adjacent ranges, for var. afghanica and var. asperrima.[5][14] Wild and feral populations persist in both regions and across the western Himalayas.[5][6]
Var. indica was historically dispersed from South Asia eastward into Southeast Asia and southward through the Indian Ocean trade network to Africa, where it became established as a drug crop in the Horn of Africa, East Africa and the Sahel.[14][5] From Africa, indica-type populations were introduced to the Americas via the Atlantic trade, where they form the basis of traditional cannabis cultures across the Caribbean and parts of South America.[14] Var. afghanica had a more restricted historical distribution centred on the Hindu Kush and adjacent regions, and remained largely unknown to outside breeding networks until the 1970s.[14][5]
The introduction of var. afghanica into European and North American breeding pools in the late twentieth century, in particular through Hindu Kush seed sourcing by hashish-trade and cannabis-cultivation networks, gave rise to the modern hybrid lineages that dominate commercial drug cannabis today.[14][5] The Hyb-Seq phylogeography of Balant et al. (2025) distributes traditional indica-type accessions across three Paleotropis subgroups: Hindu Kush and Afghan landraces fall within the Iranian Plateau subgroup; northern Indian and Nepali landraces within the Central and Southern China and Himalayas subgroup; and dispersed South Asian-origin landraces from mainland Southeast Asia, southern India and West Africa within the Indoafrica subgroup.[6]
Vernacular and commercial usage
In the commercial cannabis market since the 1980s, the terms "Sativa" and "Indica" have been applied as labels for purported effect categories distinct from their botanical references.[5][2] McPartland and Small (2020) note that the layman's "Indica" of the modern dispensary, with its short-stature, broad-leaflet, densely flowered form, corresponds to botanical var. afghanica rather than to Lamarck's var. indica.[5] The layman's "Sativa", in turn, corresponds to var. indica (Lamarck's original concept) and not to C. sativa subsp. sativa.[5]
The vernacular labels are poor predictors of chemical and pharmacological effect. Chemovar analyses found that "Sativa" and "Indica" market labels do not consistently align with cannabinoid and terpenoid profiles, and the narrow- and broad-leaflet morphological distinction is no longer a reliable indicator of either ancestry or effect in heavily hybridised commercial cultivars.[17]
Uses
Cannabis indica has been cultivated predominantly for drug production, with fibre and oilseed use historically marginal relative to C. sativa subsp. sativa.[14] Traditional drug-production systems differ between the two domesticated varieties:
Var. indica (South Asian). Traditional cultivation produces ganja (dried pistillate inflorescences) and charas (rubbed resin), with seed and stem use as secondary by-products. Landrace populations are maintained across the Himalayas, the lower Himalayan foothills of India and Nepal and in Southeast Asia.[14]
Var. afghanica (Central Asian). Traditional cultivation produces hashish (sieved or beaten compressed resin) across Afghanistan and adjacent regions of Pakistan. Moroccan kif production in the Rif Mountains, historically based on local kif landraces, has been transformed since the late twentieth and early twenty-first centuries by higher-yielding hybrid material, producing the modern Moroccan hashish populations.[18]
In the twentieth century, var. afghanica was introduced into European and North American cannabis breeding pools, where its short stature, compact form, dense flowering and early maturation made it attractive as a parent in modern hybrid cultivars.[14][5] Most commercial drug-cannabis cultivars today carry a mixture of var. indica and var. afghanica ancestry, with the relative proportion of each varying widely among lineages.[13]
Chemical variation
McPartland and Small (2020) frame C. sativa subsp. indica as the high-THC reservoir of the genus, with diagnostic THC and CBD ratios distinguishing the two domesticated varieties: var. indica populations typically show strongly THC-dominant chemotypes (chemotype I), while var. afghanica populations frequently show mixed THC/CBD profiles (chemotype II) alongside chemotype I.[5][19] CBD-dominant chemotype III plants occur in Cannabis more broadly but are not characteristic of subsp. indica as circumscribed by McPartland and Small.[5][20]
The genetic basis of THC/CBD ratio variation lies at the cannabinoid synthase loci, which have been mapped to a single genomic region containing tandemly arrayed paralogues.[21] Terpenoid profiles vary at the population level and have been investigated as a classification tool complementary to cannabinoid ratios.[17] The correspondence between terpenoid profile and the var. indica/var. afghanica distinction is not strong in heavily hybridised modern cultivars, where decades of intervariety crossing have homogenised much of the chemical variation that distinguished the wild and traditional source populations.[17][13]
See also
References
- ↑ 1.0 1.1 1.2 Lamarck, J.-B. (1785). Encyclopédie Méthodique, Botanique, vol. 1(2), p. 695. Paris: Panckoucke.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 McPartland, J.M. & Guy, G.W. (2017). Models of Cannabis taxonomy, cultural bias, and conflicts between scientific and vernacular names. Botanical Review, 83(4), 327–381. doi:10.1007/s12229-017-9187-0
- ↑ 3.0 3.1 3.2 3.3 3.4 Small, E. & Cronquist, A. (1976). A practical and natural taxonomy for Cannabis. Taxon, 25(4), 405–435. doi:10.2307/1220524
- ↑ 4.0 4.1 4.2 4.3 4.4 4.5 4.6 Small, E. (2015). Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization. Botanical Review, 81(3), 189–294. doi:10.1007/s12229-015-9157-3
- ↑ 5.00 5.01 5.02 5.03 5.04 5.05 5.06 5.07 5.08 5.09 5.10 5.11 5.12 5.13 5.14 5.15 5.16 5.17 5.18 5.19 5.20 5.21 5.22 5.23 5.24 5.25 5.26 5.27 5.28 5.29 5.30 5.31 5.32 McPartland, J.M. & Small, E. (2020). A classification of endangered high-THC cannabis (Cannabis sativa subsp. indica) domesticates and their wild relatives. PhytoKeys, 144, 81–112. doi:10.3897/phytokeys.144.46700
- ↑ 6.0 6.1 6.2 6.3 6.4 Balant, M., Vitales, D., Wang, Z., Barina, Z., Fu, L., et al. (2025). Integrating target capture with whole genome sequencing of recent and natural history collections to explain the phylogeography of wild-growing and cultivated cannabis. Plants, People, Planet, 7(6), 1771–1788. doi:10.1002/ppp3.70043
- ↑ 7.0 7.1 7.2 Schultes, R.E., Klein, W.M., Plowman, T. & Lockwood, T.E. (1974). Cannabis: an example of taxonomic neglect. Botanical Museum Leaflets, Harvard University, 23(9), 337–367.
- ↑ 8.0 8.1 8.2 8.3 8.4 Hillig, K.W. (2005). Genetic evidence for speciation in Cannabis (Cannabaceae). Genetic Resources and Crop Evolution, 52(2), 161–180. doi:10.1007/s10722-003-4452-y
- ↑ 9.0 9.1 Lapierre, É., Monthony, A.S. & Torkamaneh, D. (2023). Genomics-based taxonomy to clarify cannabis classification. Genome, 66(8), 202–211. doi:10.1139/gen-2023-0005
- ↑ Linnaeus, C. (1753). Species Plantarum, vol. 2, p. 1027. Stockholm: Laurentius Salvius.
- ↑ Vavilov, N.I. & Bukinich, D.D. (1929). Agricultural Afghanistan. Trudy po Prikladnoi Botanike, Genetike i Selektsii, 33(supplement), 1–610.
- ↑ Ren, G., Zhang, X., Li, Y., Ridout, K., Serber, M.L., et al. (2021). Large-scale whole-genome resequencing unravels the domestication history of Cannabis sativa. Science Advances, 7(29), eabg2286. doi:10.1126/sciadv.abg2286
- ↑ 13.0 13.1 13.2 13.3 Lynch, R.C., Padgitt-Cobb, L.K., Garfinkel, A.R., Knaus, B.J., Hartwick, N.T., et al. (2025). Domesticated cannabinoid synthases amid a wild mosaic cannabis pangenome. Nature, 643(8073), 1001–1010. doi:10.1038/s41586-025-09065-0
- ↑ 14.00 14.01 14.02 14.03 14.04 14.05 14.06 14.07 14.08 14.09 14.10 14.11 14.12 14.13 Clarke, R.C. & Merlin, M.D. (2013). Cannabis: Evolution and Ethnobotany. University of California Press.
- ↑ 15.0 15.1 Livingston, S.J., Quilichini, T.D., Booth, J.K., Wong, D.C.J., Rensing, K.H., et al. (2020). Cannabis glandular trichomes alter morphology and metabolite content during flower maturation. Plant Journal, 101(1), 37–56. doi:10.1111/tpj.14516
- ↑ Andre, C.M., Hausman, J.-F. & Guerriero, G. (2016). Cannabis sativa: the plant of the thousand and one molecules. Frontiers in Plant Science, 7, 19. doi:10.3389/fpls.2016.00019
- ↑ 17.0 17.1 17.2 Hazekamp, A. & Fischedick, J.T. (2012). Cannabis — from cultivar to chemovar. Drug Testing and Analysis, 4(7–8), 660–667. doi:10.1002/dta.407
- ↑ Chouvy, P.-A. & Afsahi, K. (2014). Hashish revival in Morocco. International Journal of Drug Policy, 25(3), 416–423. doi:10.1016/j.drugpo.2014.01.001
- ↑ Hillig, K.W. & Mahlberg, P.G. (2004). A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae). American Journal of Botany, 91(6), 966–975. doi:10.3732/ajb.91.6.966
- ↑ de Meijer, E.P.M., van der Kamp, H.J. & van Eeuwijk, F.A. (1992). Characterisation of Cannabis accessions with regard to cannabinoid content in relation to other plant characters. Euphytica, 62(3), 187–200. doi:10.1007/BF00041753
- ↑ Laverty, K.U., Stout, J.M., Sullivan, M.J., Shah, H., Gill, N., Holbrook, L., et al. (2019). A physical and genetic map of Cannabis sativa identifies extensive rearrangements at the THC/CBD acid synthase loci. Genome Research, 29(1), 146–156. doi:10.1101/gr.242594.118